The Impact of Antiviral (HCV) Therapy on Kidney Function in Liver Transplant Recipients

被引：0
|
作者：
Nelson, Kirbylee K. [1 ]
Caire, M. Thure [2 ]
Kumar, Ambuj [3 ]
Morano, Jamie [2 ]
Kemmer, Nyingi [4 ]
机构：
[1] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33612 USA
[2] Univ S Florida, Tampa, FL USA
[3] Univ S Florida, Div Evidence Based Med & Outcomes Res, Morsani Coll Med, Tampa, FL USA
[4] Tampa Gen Med Grp, Tampa, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-02197
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2197
引用
收藏
页码：S914 / S914
页数：1
相关论文
共 50 条
  • [1] The Impact of Antiviral (HCV) Therapy on Kidney Function in Liver Transplant Recipient
    Nelson, Kirbylee K.
    Caire, Michael T.
    Kumar, Ambuj
    Morano, Jamie
    Kemmer, Nyingi
    GASTROENTEROLOGY, 2016, 150 (04) : S1101 - S1101
  • [2] The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study
    Santonicola, Antonella
    Bilancio, Giancarlo
    Zingone, Fabiana
    Donnarumma, Laura
    Caputo, Cesare
    Ciacci, Carolina
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [3] HCV Antiviral Therapy in Liver Transplant Candidates and Recipients With Renal Insufficiency
    Verna, Elizabeth C.
    Brown, Robert S., Jr.
    TRANSPLANTATION, 2017, 101 (05) : 924 - 932
  • [4] EFFECT OF ANTIVIRAL THERAPY ON CELL MEDIATED IMMUNITY IN LIVER TRANSPLANT RECIPIENTS WITH HCV
    Woo, G. A.
    Arosemena, L.
    Tryphonopoulos, P.
    Agresti, N.
    Butt, W.
    Sclair, S.
    Schiff, E. R.
    Tzakis, A. G.
    Martin, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S97 - S97
  • [5] Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors
    Terrault, Norah A.
    Burton, James
    Ghobrial, Mark
    Verna, Elizabeth
    Bayer, Johanna
    Klein, Christina
    Victor, David
    Mohan, Sumit
    Trotter, James
    Dodge, Jennifer
    Niemann, Claus U.
    Rubin, Raymond A.
    HEPATOLOGY, 2021, 73 (06) : 2110 - 2123
  • [6] IMMUNOSUPPRESSION THERAPY DURING TREATMENT OF CHRONIC HCV INFECTION WITH NEW ANTIVIRAL DRUGS IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS
    Musialik, Joanna
    Kolonko, Aureliusz
    Karkoszka, Henryk
    Kwiecien, Katarzyna
    JeDrusik, Ewa
    Wiecek, Andrzej
    TRANSPLANT INTERNATIONAL, 2017, 30 : 232 - 233
  • [7] Viral Kinetics of De Novo HCV Infection and Response to Antiviral Therapy in Liver and Kidney Transplant Recipients Receiving HCV-Viremic Donors
    Terrault, N.
    Burton, J.
    Verna, E.
    Mobley, C.
    Victor, D.
    Trotter, J.
    Niemann, C.
    Rubin, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 828 - 828
  • [8] INTERACTIONS BETWEEN IMMUNOSUPPRESSIVE THERAPY AND DIRECT ACTING ANTIVIRAL IN KIDNEY TRANSPLANT RECIPIENTS WITH HCV INFECTION
    Carta, Paolo
    Curci, Federica
    Di Maria, Lorenzo
    Larti, Aida
    Caroti, Leonardo
    Cirami, Lino
    TRANSPLANT INTERNATIONAL, 2019, 32 : 169 - 169
  • [9] Impact of optimization of antiviral therapy and removal of cytomegalovirus immune globulin on clinical outcomes in liver and combined liver/kidney transplant recipients
    Jebrock, Jennifer
    Price, Venessa
    Centeno, Alexandra
    Abbo, Lilian
    Morris, Michele
    Tzakis, Andreas G.
    PHARMACOTHERAPY, 2012, 32 (10): : E249 - E249
  • [10] Impact of Optimization of Antiviral Therapy and Removal of Cytomegalovirus Immune Globulin on Clinical Outcomes in Liver and Combined Liver/Kidney Transplant Recipients
    Jebrock, J.
    Price, V.
    Centeno, A.
    Abbo, L.
    Morris, M.
    Tzakis, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 471 - 471
12345